Anthem Biosciences Limited is going to launch its IPO on July 14, 2025, the objective of raising 3584.50 crores from the market. The closing date of the IPO is July 16, 2025, and it will be listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) on July 21, 2025.
About company
Anthem Biosciences is a leading Contract Research and Innovation Service Provider (CRISP) based in Bangalore, India. The company operates from two state-of-the-art facilities, where it hosts over 1,000 researchers and manufactures innovative commercial drug actives.
Since starting operations in 2007, Anthem has built a strong reputation in drug discovery, product development, and manufacturing. It offers chemistry and biology-based services, supporting both biotech startups and global pharmaceutical companies.
Anthem’s expert team of chemists, biologists, and engineers ensures transparent, ethical collaboration with clients. Its labs have successfully developed, optimized, and tested a wide range of products, including proteins, monoclonal antibodies, peptides, small molecules, large molecules, and toxins.
In addition to R&D, Anthem provides:
- Safety and efficacy testing (in vitro and in vivo)
- Pre-clinical studies in GLP-certified facilities
- Clone development and Antibody Drug Conjugates (ADCs)
- Highly potent compound development
- Flow chemistry and large-scale GMP manufacturing
Anthem has passed regulatory inspections from USFDA, PMDA (Japan), and EU QPs, showcasing its global compliance standards.
Anthem Biosciences uses advanced infrastructure to perform GMP synthesis from milligram to multi-ton scale. It operates modern labs, a cGMP kilo lab, and a flexible GMP pilot plant to ensure efficient and scalable production.
IPO details of Anthem Biosciences
| IPO Date | 14 July 2025 to 16 July 2025 |
| Offer Price | 540 to 570 per share |
| Lot Size | 26 Share |
| Max Retail Subscription (In Rs.) | 5 lakhs |
| Face Value | 2 per share |
| Issue Size (In Cr.) | 3584.50 |
| Issue Type | Book Building |
| Listing In | NSE, BSE |
Investor category allocation of Anthem Biosciences IPO
| Investor category | Shares Offered | Allocation % |
| Retail Individuals | 20795833 | 34.91% |
| Anchor Investors | 17825000 | 29.93% |
| QIBs | 11883333 | 19.95% |
| NIIs/HNIs | 8912500 | 14.96% |
| Employees | 144737 | 0.24% |
| Total | 59561403 | 100% |
Anthem Biosciences (IPO Schedule):
| IPO Open Date | 14 July 2025 |
| IPO Close Date | 16 July 2025 |
| UPI Mandate deadline | 16 July 2025 (5 PM) |
| Allotment Date | 17 July 2025 |
| Refund Initiation | 18 July 2025 |
| Demat Transfer | 18 July 2025 |
| Listing Date | 21 July 2025 |
Financial Information of Anthem Biosciences IPO
| Financial End | March 2022 | March 2023 | March 2024 | March 2025 |
| Total Assets (In Cr.) | 1618.87 | 2014.46 | 2398.11 | 2807.58 |
| Revenue (In Cr.) | 1280.24 | 1133.99 | 1483.07 | 1930.29 |
| Profit After Tax (In Cr.) | 405.54 | 385.19 | 367.31 | 451.26 |
| Net Worth | 1355.47 | 1740.67 | 1924.66 | 2409.86 |
Objective of Anthem Biosciences IPO
(i) To carry out the Offer for Sale of up to [●] Equity Shares of face value of 2 each by the selling Shareholders aggregating up to 33,950.00
(ii) Achieve the benefits of listing the Equity Shares on the Stock Exchanges.
List of Promoters
Ajay Bhardwaj
Ishaan Bhardwaj
Ganesh Sambasivam
K Ravindra Chandrappa
Prospectus of Anthem Biosciences IPO
Registered Address of Anthem Biosciences IPO
Anthem Biosciences Limited
No. 49, F1 & F2, Canara Bank Road
Bommasandra Industrial Area
Phase 1, Bommasandra, Bangalore
Karnataka, India, 560 099
Telephone: +91 080 6672 4000
E-mail: investors.abl@anthembio.com
Website: www.anthembio.com
Anthem Biosciences IPO Registrar
KFin Technologies Limited
Selenium, Tower B, Plot No –31 and 32
Financial District, Nanakramguda, Serilingampally
Hyderabad, Rangareddy – 500 032
Telangana, India
Telephone: +91 40 6716 2222
E-mail: anthem.ipo@kfintech.com
Investor grievance E-mail: einward.ris@kfintech.com
Website: www.kfintech.com
Anthem Biosciences IPO Lead Manager
JM Financial Limited
J.P. Morgan India Private Limited
Citigroup Global Markets India Private Limited
Nomura Financial Advisory and Securities (India) Private Limited
Anthem Biosciences IPO FAQs
Q. What is Anthem Biosciences IPO?
A. Anthem Biosciences IPO is a Regular IPO. The IPO is to be listed on NSE, BSE.
Q. When Anthem Biosciences IPO will open for subscription?
A. The IPO is to open on 14 July 2025. The IPO will close on 16 July 2025.
Q. What is Anthem Biosciences IPO Issue Size?
A. Anthem Biosciences IPO issue size is 3584.50 crores.
Q. What is Anthem Biosciences IPO Price Band?
A. Anthem Biosciences IPO Price Band is 540 to 570.
Q. What is Anthem Biosciences IPO Lot Size?
A. The minimum bid is 26 Shares with 14820 amount.
Q. What is the Anthem Biosciences IPO Allotment Date?
A. Anthem Biosciences IPO allotment date is 17 July 2025.
Q. What is the Anthem Biosciences IPO Listing Date?
A. Anthem Biosciences IPO listing date is 21 July 2025.